Electroconvulsive Therapy in Schizophrenia: Exploratory Study on the Efficacy, Cognitive Effects, and Safety of Right Unilateral Versus Bitemporal Techniques

精神分裂症电休克疗法:右侧单侧与双颞侧电休克疗法的疗效、认知效应和安全性探索性研究

阅读:2

Abstract

INTRODUCTION: Electroconvulsive therapy (ECT) is an effective treatment for resistant schizophrenia, although debate persists about the optimal electrode placement technique. Bitemporal stimulation (BTS) is the most commonly used, while right unilateral stimulation (RUS) is associated with fewer cognitive effects in other disorders. METHODS: Exploratory study including 17 patients randomized to BTS (n = 8) or RUS (n = 9). Symptoms and severity were assessed with the Positive and Negative Symptom Scale (PANSS) and Clinical Global Impression (CGI) scale, cognitive functions with Montreal Cognitive Assessment (MoCA) and Brief Assessment of Cognitive in Schizophrenia (BACS). Symptomatic changes, frequency and time of onset of side effects, changes in cognitive performance, and specific functions were compared. RESULTS: Both groups showed significant improvement in symptoms (ΔPANSS: BTS = 44.75 vs. RUS = 39.11; p = 0.724), with no differences in response rates (75% BTS vs. 44.4% RUS; p = 0.335). RUS required a lower stimulus to induce seizures (29.8 mC vs. 54 mC in BTS; p = 0.003). The BTS group showed deterioration in verbal fluency (BACS: p = 0.042), while the RUS showed improvement in motor speed (p = 0.046). There were no global differences in MoCA or BACS. CONCLUSION: Both techniques are equally effective in symptomatic reduction, but RUS could offer advantages as it requires less load and is associated with less deterioration in verbal fluency. These preliminary results have methodological limitations, mainly the sample size and lack of power calculation, but they may encourage further research. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT06972745.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。